Autolus Therapeutics (AUTL) Change in Receivables (2025)

Name: Autolus Therapeutics (AUTL) Change in Receivables (2025) | Business Quant
Creator: Business Quant

Autolus Therapeutics posted quarterly Change in Receivables of -$8.6 million for Q4 2025, down 242.79% on a QoQ basis from $6.0 million in Q3 2025.

Autolus Therapeutics (AUTL) has 1 years of Change in Receivables data on file, last reported at -$8.6 million in Q4 2025.

For the quarter ending Q4 2025, Change in Receivables changed N/A year-over-year to -$8.6 million; the trailing twelve-month figure through Dec 2025 stood at $24.2 million (changed N/A YoY), and the FY2025 full-year result was $24.2 million, changed N/A from the prior year.
Change in Receivables for Q4 2025 stood at -$8.6 million, down from $6.0 million in the prior quarter.
Across five years, Change in Receivables topped out at $14.3 million in Q1 2025 and bottomed at -$8.6 million in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Quantum Biopharma	1,384,976.65 Bn	1,384,976.64 Bn	-	208,524.00
2	Alterity Therapeutics	777,208.84 Bn	777,208.81 Bn	-	-
3	Legend Biotech	2,801.00 Bn	2,800.10 Bn	242.10 Mn	-
4	Nanobiotix	2,226.01 Bn	2,225.95 Bn	-	-
5	Akari Therapeutics	605.66 Bn	605.66 Bn	-	-
6	Vertex Pharmaceuticals	110.17 Bn	102.92 Bn	2.59 Bn	-39.80 Mn
7	Regeneron Pharmaceuticals	66.86 Bn	58.11 Bn	3.31 Bn	-1.20 Mn
8	Evaxion A	65.12 Bn	65.10 Bn	-	-
9	Alnylam Pharmaceuticals	39.94 Bn	36.94 Bn	959.66 Mn	110.42 Mn
10	Autolus Therapeutics	-	-	-1.04 Mn	-8.57 Mn

Download Data 🔒